Posted 27th May 2020 by Liv Sewell
The present COVID-19 crisis has demonstrated the vital need for knowledge sharing across the global science community. We asked three of our speakers what international collaboration means for them as leaders in their fields.
Posted 11th May 2020 by Liv Sewell
International collaboration and travel are integral to the life of researchers and biotechnology professionals. But coronavirus has made travel impossible.
We look back over two decades of growth in international scientific collaboration to understand the extent of the effects of reduced mobility and consider what collaboration will look like in the foreseeable future.
Posted 27th April 2018 by Jane Williams
The blockchain technology market is expected to grow to 2.3 billion US dollars by 2021, from 339.5 million US dollars in 2017.  With an annual growth rate of 61.5%, it is one of the fastest growing technologies in the healthcare industry.
Posted 25th April 2018 by Jane Williams
The microfluidic-based devices market has been growing since 2014 due to the increasing point of care testing demand and the miniaturisation of microfluidic chips.
Posted 16th April 2018 by Jane Williams
The amount of data we are creating every day has increased exponentially to match the rise in use of smart and connected devices. The internet of things has connected every aspect of our lives to the digital realm: most of these devices operate by tracking your habits, movements, preferences, voice, and more, then logging those habits online. Specifically, the collection of health data has become abundant, because most people now have or wear some sort of device to track daily patterns, steps, cycles, and more. Even our phones often default to track these things for us, whether we choose to enable the function or not.
Posted 7th February 2018 by Jane Williams
What is the blockchain?
According to a recent Forbes article: the blockchain is one of the most misunderstood technologies of 2017 (1). While most healthcare professionals have heard the term “blockchain” and are aware of the innovations in financial technology, few understand the fundamental principles behind the technology in order to speculate the impacts it will have on the healthcare industry, at hospitals, and for patients. This inability is common across sectors and can be attributed to the absence of any standard definition of blockchain technology. However, it is important that industry leaders have a firm basis for understanding it in order to foresee its impacts on their business. What follows is a list of key points for understanding the blockchain and enabling speculation on its impacts in healthcare:
Posted 1st December 2017 by Jane Williams
We were delighted to welcome Professor George Whitesides to the 2nd Microfluidics Congress: USA. If you weren’t able to make it, you can watch his presentation in full here.
Posted 22nd November 2017 by Jane Williams
Synthetic biology holds much promise. Researchers have been working toward using techniques to create new valuable products such as novel therapeutics and drugs, biorenewable fuels, and new biochemicals and biomaterials. It requires a multidisciplinary effort – it calls for biologists, chemists, engineers, software developers (STEM disciplines) to collaborate on finding ways to understand how genetic parts work together, and then combine them to produce useful applications.